Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJames Halstead Regulatory News (JHD)

Share Price Information for James Halstead (JHD)

Share Price is delayed by 15 minutes
Get Live Data
124.60    -1.80 (-1.42%)
Bid:
124.00
Ask:
125.00
Spread: 1.00 (0.806%)
Market Cap: £518.85m
JHD Live PriceLast checked at - London Stock Exchange

Intraday James Halstead Share Chart

Pre-close Trading Statement

26 Jul 2011 07:00

RNS Number : 0254L
James Halstead PLC
26 July 2011
 



 

 

26 July 2011

 

James Halstead plc

 

Pre-close Trading Statement

 

"Continues robust trading and confident of reporting record profit"

 

James Halstead plc, the commercial flooring manufacturer and distributor, is providing the following trading update prior to entering the close period ahead of its results for the year to 30 June 2011.

 

In its interim results statement issued on 31 March 2011, the Company stated that: "The first half year trading was very solid with record revenue representing an increase of 15.2%. The Chairman, Mr. Geoffrey Halstead expressed confidence that the Company would forge ahead in the second half year.

 

Overall, this confidence was well founded and the Company has continued to trade robustly. Trading performances across the Company's export markets have remained strong and overall turnover should have increased by around 15%. The growth in our export markets is particularly strong and it is too simplistic to put this down to the value of sterling. Our exports have grown over a generation and we are well placed to continue supplying flooring to major infrastructure projects across the globe.

 

In the UK the commercial flooring market place has declined as might be expected in a building recession. Notwithstanding this, we expect turnover in the UK to be ahead of last year. Our home market has faced the challenges of price competition (as manufacturers look to hold on to volume) and an estimated 16% decline in the market for sheet vinyl. One of our key strengths is in refurbishment, but several large flooring contractors have gone out of business which has frustrated the smooth flow of ongoing refurbishment spending. None of this was unexpected and the UK commercial flooring market continues to be challenging.

 

Notwithstanding these problems, we have increased turnover in the UK, partly as a result of increased market share but also as a result of significant growth in sourced product which has crossed over from its target market of "light contract" into the "heavy domestic" marketplace. With the same route to market as commercial flooring, through flooring distributors, we have encouraged this expansion.

 

Rising raw material and energy costs have continued to impact on margins though there are some compensatory effects of which the most significant is improved margins on increased international sales. Our cash balances and even after dividends, acquisitions and plant expenditure it should exceed the levels of last year.

 

Riverside Flooring Ltd, the newest addition to the Group, which was acquired in November 2010, has incurred some significant costs as we tested, adapted and re-commissioned the plant. Previously the plant used to make domestic cushion vinyl.

 

Taking all the above into consideration the Board is confident that the Company will report another year of record profits for the year ended 30 June 2011 in line with market expectations.

 

Enquiries:

 

James Halstead

0161 767 2500

Mark Halstead, Chief Executive

Gordon Oliver, Finance Director

Hudson Sandler

020 7796 4133

Michael Sandler

Altium

020 7484 4040

Ben Thorne

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTQELFLFDFXBBX
Date   Source Headline
25th Jan 20107:00 amRNSPre-close Trading Statement
4th Jan 20107:00 amRNSBlocklisting Interim Review
31st Dec 20097:00 amRNSTotal Voting Rights
18th Dec 20094:00 pmRNSAnnual Report and Accounts
14th Dec 200911:30 amRNSDirector's shareholding
10th Dec 20093:00 pmRNSDirector's shareholding
7th Dec 20091:50 pmRNSDirector's shareholding
4th Dec 20091:00 pmRNSDividend Declaration
4th Dec 20097:00 amRNSAGM Statement
12th Oct 200912:00 pmRNSDirector/PDMR Shareholding
29th Sep 20097:00 amRNSPreliminary Results
17th Sep 200911:37 amRNSNotice of Preliminary Results
29th Jul 20097:00 amRNSPre-Close Trading Update
1st Jul 200912:30 pmRNSBlocklisting Interim Review
30th Mar 20094:45 pmRNSDividend Declaration - Correction
30th Mar 20097:00 amRNSInterim Results
17th Mar 20093:12 pmRNSNotice of Results
26th Feb 20098:00 amRNSBlocklisting Interim Review
28th Jan 20097:00 amRNSPre-close Trading Statement
22nd Dec 200812:30 pmRNSAnnual Report and Accounts
10th Dec 20087:00 amRNSAGM Statement
8th Oct 200812:00 pmRNSDirector/PDMR Shareholding
6th Oct 20085:00 pmRNSDirector/PDMR Shareholding
30th Sep 20085:08 pmRNSDirectors' Dealings
30th Sep 20087:00 amRNSFinal Results
24th Sep 20087:00 amRNSExecutive Board Appointment
19th Sep 20084:50 pmRNSSecond Price Monitoring Extn
19th Sep 20084:35 pmRNSPrice Monitoring Extension
16th Sep 200810:00 amRNSNotice of Results
4th Sep 20087:00 amRNSNotice of Results
31st Jul 20087:00 amRNSTotal Voting Rights
3rd Jul 20081:00 pmRNSBlocklisting Interim Review
1st Jul 20087:00 amRNSTrading Statement
11th Jun 20081:00 pmRNSAdditional Listing
30th May 200810:58 amRNSTotal Voting Rights
14th May 20087:00 amRNSDirector/PDMR Shareholding
31st Mar 20087:00 amRNSInterim Results
1st Feb 20084:50 pmRNSTotal Voting Rights
31st Jan 20083:49 pmRNSAdditional Listing
30th Jan 20082:16 pmRNSDirector/PDMR Shareholding
28th Jan 20087:00 amRNSPre-close Trading Update
23rd Jan 20084:31 pmRNSBlock Listing Returns
15th Jan 20081:11 pmRNSDirector/PDMR Shareholding
7th Jan 200812:43 pmRNSDirector/PDMR Shareholding
7th Dec 20077:01 amRNSAGM Statement
15th Nov 200710:56 amRNSAnnual Report and Accounts
1st Oct 20077:01 amRNSFinal Results
10th Sep 20079:38 amRNSNotice of Results
31st Aug 20073:33 pmRNSTotal Voting Rights
23rd Aug 20071:21 pmRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.